BioGend Therapeutics Co., Ltd. (TPEX: 6733)
Health Care · Biotechnology · TW
NT$24.90
-0.80% today · -42.0% 1Y
BioGend Therapeutics Co., Ltd. (TPEX: 6733) operates in the Biotechnology industry within the Health Care sector. The company is valued at $104.60M and employs 34 people.
Over the last twelve months the share price has lost 42.0%, trading between 23.45 and 46.75.
Tweenvest scores BioGend Therapeutics Co., Ltd. across four factors: quality 50/100, value 85/100, growth 100/100. Its strongest factor is growth.
6733 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $104.60M
- Revenue (TTM)
- $7.44M
- P/E
- —
- EPS
- -0.54
- Dividend yield
- —
- Beta (5Y)
- 0.08
- 52-week high
- NT$46.75
- 52-week low
- NT$23.45
- Avg volume (3M)
- —
- Shares outstanding
- 134.32M
- Employees
- 34
- Next earnings
- —
About BioGend Therapeutics Co., Ltd.
This company specializes in the development of innovative regenerative bio-orthopedic products. Its current pipeline includes BiG-001 and BiG-006, both of which are osteoinductive bone graft substitutes. Additionally, it is advancing BiG-009, an autologous cartilage repair system. Established in 2016, the firm's operations are based in Taipei, Taiwan.
- ISIN
- TW0006733009
- Founded
- 2016
- Listed since
- Jun 18, 2019
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tenax Therapeutics, Inc.NasdaqCM: TENX | $107.12M | $1.63 | -13.10% |
| Maxigen Biotech Inc.TWSE: 1783 | $106.88M | NT$38.10 | +2.83% |
| Tevogen Inc.NasdaqGM: TVGN | $106.69M | $7.15 | +5.46% |
| Vaxart, Inc.OTCPK: VXRT | $105.65M | $0.43 | -0.59% |
| Paradigm Biopharmaceuticals LimitedASX: PAR | $104.36M | AU$— | — |
| Corbus Pharmaceuticals Holdings, Inc.NasdaqCM: CRBP | $104.06M | $4.78 | -11.15% |
| Captor Therapeutics Spolka AkcyjnaWSE: CTX | $103.78M | zł60.00 | -6.25% |
| Shine-On BioMedical Co.,Ltd.TPEX: 6926 | $103.57M | NT$66.50 | -1.04% |
Figures last refreshed Oct 11, 2026.